Back to mobile site

Piper Jaffray Defends Alexion Pharmaceuticals (ALXN)

August 30, 2019 10:44 AM EDT Send to a Friend
Piper Jaffray analyst Chris Raymond reiterated an Overweight rating and $180.00 price target ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login